Consequently, increased intracellular Gal-9 expression in cancer cells is associated with reduced metastatic potential, which may account for the improved overall survival OS and RFS outcomes observed in patients with solid malignancy, in particular gastrointestinal cancers. This evidence concerns the gene LGALS9 and cancer.